FROM GOOGLE TRANSLATE Quantitative testing of blood-related diseases contribute to the diagnosis of Neuroscience Publication of the _COM_GLOBAL_CURRENT_SITENAME Posted on 14 Dec 2010
For in vitro diagnostic devices (IVDD) in the quantitative measurement of molecular nanotechnology could be the blood parameters, through specific biomarkers for assessment of brain neural input and output.
A reliable quantitative blood test 12 new combination products for general practitioners and specialists to provide diagnostic neuroscience-related disease or injury in the pathophysiology of clinical parameters required. This is the blood and other body fluids by identifying specific biomarkers of abnormal readings to achieve.
Blood tests will be used to detect, prevent, monitor and track the major social stress-related professional and occupational diseases. These include chronic fatigue syndrome (CFS), severe anxiety (GA), panic disorder (PS), neuropathy, or fibromyalgia (FM), some cardiovascular disease, Alzheimer's disease and Parkinson's disease and other neurological Tissue degenerative diseases, as well as depression and schizophrenia and other mental health disorders.
The product from the Neuro-Biotech Corporation (Basel, Switzerland, neuro-biotechcorp.com) development, is a non-invasive, sensitive, reliable and fast diagnostic test products out of the results. They will improve the existing clinical laboratory test procedures.
Neuro-Biotech companies in the clinical neuroscience expertise so that they can fully understand how the family of brain neurotransmitters in different ways under the influence of pituitary adrenal - sympathetic (HPAS) axis involved in the peripheral nervous system. HPAS conditioning shaft in response to pressure state of bodily functions and maintain homeostasis to the body by the immune and endocrine systems Psychoneuroimmunology against the psychological and social environment.
News 
Market Data 
Discover 
AI
